FDA Approved: PROGRAF — Supplemental Application (Astellas Pharma US, Inc.)

View source ↗

Summary

FDA approved a supplemental application for PROGRAF (tacrolimus) from Astellas Pharma US, expanding or updating its labeling and indications for transplant-rela…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Heart Transplant Rejection
• Kidney Transplant Rejection
• Liver Transplant Rejection

Drugs mentioned

• Prograf (Tacrolimus)

Snippet

SUPPL AP for PROGRAF (TACROLIMUS)